Variant report
Variant | nsv562721 |
---|---|
Chromosome Location | chr13:92476602-92548841 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GPC6-3 | chr13:92508013-92508180 | NONHSAT034698 |
2 | lnc-GPC6-3 | chr13:92506911-92506952 | NONHSAT034698 |
3 | lnc-GPC6-4 | chr13:92484168-92484579 | l_901_chr13:92483239-92484579_testes |
4 | lnc-GPC6-4 | chr13:92483240-92483466 | l_901_chr13:92483239-92484579_testes |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9523424 | chr13:92476602-92476603 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs9515980 | chr13:92476627-92476628 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs556115619 | chr13:92476648-92476649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs199655539 | chr13:92476697-92476698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191317073 | chr13:92476720-92476721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182310265 | chr13:92476750-92476751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187014399 | chr13:92476792-92476793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368227334 | chr13:92476800-92476801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549115704 | chr13:92476840-92476841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191914801 | chr13:92476858-92476859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs368126047 | chr13:92476884-92476885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs149975140 | chr13:92476951-92476952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs117924867 | chr13:92476971-92476972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1332093 | chr13:92477056-92477057 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs185151333 | chr13:92477099-92477100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564813848 | chr13:92477121-92477122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533654045 | chr13:92477128-92477129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11838400 | chr13:92477140-92477141 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs188767383 | chr13:92477190-92477191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531165270 | chr13:92477254-92477255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548267388 | chr13:92477300-92477301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568056761 | chr13:92477336-92477337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549644406 | chr13:92477370-92477371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs193066783 | chr13:92477410-92477411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147885671 | chr13:92477499-92477500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570441309 | chr13:92477507-92477508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539368746 | chr13:92477508-92477509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185543760 | chr13:92477614-92477615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs75184622 | chr13:92477649-92477650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535436811 | chr13:92477658-92477659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs116443724 | chr13:92477679-92477680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572442364 | chr13:92477699-92477700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567810251 | chr13:92477731-92477732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs541682498 | chr13:92477792-92477793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564650767 | chr13:92477827-92477828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs189399022 | chr13:92477962-92477963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544135381 | chr13:92477963-92477964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139861063 | chr13:92478007-92478008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531380882 | chr13:92478105-92478106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs76867293 | chr13:92478143-92478144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145497732 | chr13:92478165-92478166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs76872569 | chr13:92478195-92478196 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567611177 | chr13:92483249-92483250 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs192534346 | chr13:92483250-92483251 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs547957630 | chr13:92483254-92483255 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs538374454 | chr13:92483264-92483265 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs368944455 | chr13:92483310-92483311 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs533848900 | chr13:92483365-92483366 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs556262468 | chr13:92484231-92484232 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs570005601 | chr13:92484263-92484264 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:92476200-92478200 | Enhancers | Fetal Lung | lung |
2 | chr13:92477200-92478200 | Weak transcription | Brain Anterior Caudate | brain |
3 | chr13:92495200-92495600 | Enhancers | Colon Smooth Muscle | Colon |
4 | chr13:92527200-92528200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr13:92528000-92528600 | Enhancers | Primary hematopoietic stem cells | blood |
6 | chr13:92528400-92528800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr13:92535400-92535800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr13:92538400-92543400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr13:92540800-92541400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:92542400-92542800 | Enhancers | Liver | Liver |
11 | chr13:92542400-92542800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr13:92542400-92543800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr13:92542400-92544000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr13:92543000-92543600 | Enhancers | Primary hematopoietic stem cells | blood |
15 | chr13:92543400-92543800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr13:92543600-92550400 | Weak transcription | Primary hematopoietic stem cells | blood |
17 | chr13:92546400-92547400 | Enhancers | HUVEC | blood vessel |
18 | chr13:92546800-92547600 | Enhancers | Fetal Muscle Leg | muscle |
19 | chr13:92547400-92548600 | Weak transcription | HUVEC | blood vessel |
20 | chr13:92548600-92550000 | Enhancers | HUVEC | blood vessel |